333 related articles for article (PubMed ID: 15045710)
1. [Rituximab. A monoclonal CD20 antibody--hematological indications and possible treatments for immunoinflammatory diseases].
Hansen PB; Hasselbalch HC
Ugeskr Laeger; 2004 Feb; 166(6):466-9. PubMed ID: 15045710
[No Abstract] [Full Text] [Related]
2. Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.
Dierickx D; Delannoy A; Saja K; Verhoef G; Provan D
Am J Hematol; 2011 Mar; 86(3):278-91. PubMed ID: 21328427
[TBL] [Abstract][Full Text] [Related]
3. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.
Rao A; Kelly M; Musselman M; Ramadas J; Wilson D; Grossman W; Shenoy S
Pediatr Blood Cancer; 2008 Apr; 50(4):822-5. PubMed ID: 17570702
[TBL] [Abstract][Full Text] [Related]
4. Rituximab in the treatment of autoimmune haematological disorders.
Provan D; Newland AC; Amadori S; Stasi R
Br J Haematol; 2008 Oct; 143(2):294; author reply 295. PubMed ID: 18752592
[No Abstract] [Full Text] [Related]
5. The late adverse events of rituximab therapy--rare but there!
Ram R; Ben-Bassat I; Shpilberg O; Polliack A; Raanani P
Leuk Lymphoma; 2009 Jul; 50(7):1083-95. PubMed ID: 19399690
[TBL] [Abstract][Full Text] [Related]
6. Rituximab in the treatment of autoimmune haematological disorders.
Garvey B
Br J Haematol; 2008 Apr; 141(2):149-69. PubMed ID: 18318765
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal antibodies in hematologic oncology].
Kuliczkowski K; Podolak-Dawidziak M
Pol Arch Med Wewn; 2002 May; 107(5):469-73. PubMed ID: 12189920
[No Abstract] [Full Text] [Related]
8. Abbreviated dose rituximab for immune-mediated hematological disorders.
Fairweather H; Tuckfield A; Grigg A
Am J Hematol; 2008 Jul; 83(7):554-7. PubMed ID: 18314916
[TBL] [Abstract][Full Text] [Related]
9. A review of rituximab in cutaneous medicine.
Scheinfeld N
Dermatol Online J; 2006 Jan; 12(1):3. PubMed ID: 16638371
[TBL] [Abstract][Full Text] [Related]
10. Antibodies and hematologic malignancies.
Smith MR
Cancer J; 2008; 14(3):184-90. PubMed ID: 18536558
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of rituximab and its clinical use: thought for the best use?
Cartron G; Blasco H; Paintaud G; Watier H; Le Guellec C
Crit Rev Oncol Hematol; 2007 Apr; 62(1):43-52. PubMed ID: 17287129
[TBL] [Abstract][Full Text] [Related]
12. Rituximab: therapeutic benefit! Vitamin R?
Mo C; Vire B; Wiestner A
Semin Hematol; 2010 Apr; 47(2):105-6. PubMed ID: 20350656
[No Abstract] [Full Text] [Related]
13. [Treatment of hematologic neoplasms during pregnancy].
Tartas NE; Foncuberta MC; Avalos JC
Medicina (B Aires); 2007; 67(6 Pt 2):729-36. PubMed ID: 18422070
[TBL] [Abstract][Full Text] [Related]
14. Rituximab therapy for autoimmune haematological diseases.
Barcellini W; Zanella A
Eur J Intern Med; 2011 Jun; 22(3):220-9. PubMed ID: 21570637
[TBL] [Abstract][Full Text] [Related]
15. Newer monoclonal antibodies for hematological malignancies.
Castillo J; Winer E; Quesenberry P
Exp Hematol; 2008 Jul; 36(7):755-68. PubMed ID: 18565392
[TBL] [Abstract][Full Text] [Related]
16. [The treatment of chronic hemoblastosis with new cytostatic agents].
Quattrin N
Minerva Med; 1966 Mar; 57(25):1141-3. PubMed ID: 5932017
[No Abstract] [Full Text] [Related]
17. Reactivation of hepatitis B virus with rituximab.
Tsutsumi Y; Kanamori H; Mori A; Tanaka J; Asaka M; Imamura M; Masauzi N
Expert Opin Drug Saf; 2005 May; 4(3):599-608. PubMed ID: 15934864
[TBL] [Abstract][Full Text] [Related]
18. Antibody-drug conjugates in hematologic malignancies.
Leslie LA; Younes A
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714472
[TBL] [Abstract][Full Text] [Related]
19. [Rituximab in the treatment of B-cell non-Hodgkin lymphoma].
Mitrović Z; Aurer I
Lijec Vjesn; 2006; 128(1-2):36-42. PubMed ID: 16640226
[TBL] [Abstract][Full Text] [Related]
20. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
